×

Azetidine and cyclobutane derivatives as JAK inhibitors

DC
  • US 8,420,629 B2
  • Filed: 12/09/2011
  • Issued: 04/16/2013
  • Est. Priority Date: 03/11/2008
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating rheumatoid arthritis in a patient comprising administering to said patient a therapeutically effective amount of {1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, provided that treating is not preventing.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×